| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.911 | 146 | 4 | 1986 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.967 | 120 | 5 | 1990 | 2018 | ||||||||
|
prolactin | 0.406 | 0.885 | 2.9E-07 |
|
group | 0.400 | None | 0.981 | 107 | 0 | 1981 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.959 | 97 | 2 | 1996 | 2019 | ||||||||
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
group | 0.100 | None | 0.948 | 97 | 0 | 1990 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.100 | None | 0.989 | 94 | 0 | 1985 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.400 | None | 0.944 | 90 | 2 | 1991 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.981 | 52 | 2 | 2002 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.100 | None | 0.913 | 46 | 2 | 1994 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 37 | 0 | 1995 | 2020 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
group | 0.100 | None | 0.886 | 35 | 1 | 1994 | 2018 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 5 | 0.560 | 0.577 | 3.4E-04 |
|
group | 0.400 | None | 1.000 | 34 | 2 | 2012 | 2019 | ||||||||
|
mutY DNA glycosylase | 0.521 | 0.769 | 1.3E-18 |
|
group | 0.100 | None | 1.000 | 29 | 3 | 2002 | 2017 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
group | 0.400 | None | 0.926 | 27 | 1 | 1993 | 2013 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
group | 0.100 | None | 0.960 | 25 | 0 | 1995 | 2019 | ||||||||
|
GNAS complex locus | 0.420 | 0.885 | 0.68 |
|
group | 0.100 | None | 1.000 | 23 | 1 | 1995 | 2018 | ||||||||
|
POU class 1 homeobox 1 | 0.548 | 0.654 | 4.5E-02 |
|
group | 0.100 | None | 1.000 | 23 | 0 | 1993 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 1.000 | 22 | 0 | 1995 | 2020 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.100 | None | 0.952 | 21 | 0 | 1994 | 2019 | |||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.100 | None | 1.000 | 21 | 0 | 1996 | 2017 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
group | 0.100 | None | 0.950 | 20 | 0 | 1994 | 2019 | |||||||||
|
O-6-methylguanine-DNA methyltransferase | 0.412 | 0.885 | 1.2E-07 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 2000 | 2017 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.950 | 20 | 0 | 1994 | 2011 | ||||||||
|
solute carrier family 20 member 1 | 0.582 | 0.577 | 6.7E-02 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1993 | 2019 | ||||||||
|
cell division cycle 73 | 0.543 | 0.615 | 1.00 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 1998 | 2019 |